Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IDO1 | P14902 | 3/20 | 0.66 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | MAPT | P10636 | 4/20 | 0.57 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.57 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.57 |
| ▸ | HPGD | P15428 | 2/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | TP53 | P04637 | 1/20 | 0.57 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.56 |
| ▸ | GAA | P10253 | 4/20 | 0.51 |
| ▸ | GFER | P55789 | 1/20 | 0.51 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.50 |
| ▸ | KLKB1 | P03952 | 1/20 | 0.49 |
| ▸ | TLR2 | O60603 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29500198 | 1.00 | IDO1 (0.66) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL27792889 | 0.98 | IDO1 (0.69) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| Acetic Acid SCHEMBL29739769 | 0.91 | IDO1 (0.57) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| Acetic Acid SCHEMBL20596710 | 0.91 | IDO1 (0.57) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| SCHEMBL16088316 | 0.85 | TAAR1 (0.67) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| SCHEMBL20798298 | 0.84 | CALM1 (0.54) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| Hydrochloric Acid SCHEMBL16037890 | 0.83 | IDO1 (0.65) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| SCHEMBL9576160 | 0.82 | ALOX5 (0.66) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| SCHEMBL786629 | 0.82 | IDO1 (0.44) | IDO1ALOX5PTGS2MAPTALDH1A1 | |
| SCHEMBL828720 | 0.82 | IDO1 (0.62) | IDO1ALOX5PTGS2MAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 135 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3510014-B1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NASH OR ALD | METABOLIC TECH INC (US) | 2026-04-29 | — | — | EP | disclosed |
| US-20250360094-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | MTI BIOTECH INC (US) | 2025-11-27 | — | — | US | disclosed |
| US-12383515-B2 | Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver | MTI BIOTECH, INC. (US) | 2025-08-12 | — | — | US | disclosed |
| CN-119345198-A | Compositions comprising gamma-keto aldehyde scavengers and uses thereof | 代谢科技有限公司 | 2025-01-24 | — | — | CN | disclosed |
| EP-3229771-B1 | 6-ARYL-9-GLYCOSYLPURINES AND USE THEREOF | UNIV PALACKEHO (CZ) | 2024-04-03 | — | — | EP | disclosed |
| US-20240000726-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | VANDERBILT UNIVERSITY | 2024-01-04 | — | — | US | disclosed |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | VANDERBILT UNIVERSITY | 2023-11-16 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | VANDERBILT UNIVERSITY | 2023-11-09 | — | — | US | disclosed |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | MTI BIOTECH, INC. | 2023-10-19 | — | — | US | disclosed |
| CN-1556808-A | Based on N6Heterocyclic compounds of substituted adenine, process for their preparation, their use for the preparation of medicaments, cosmetic preparations and growth regulators, pharmaceutical preparations, cosmetic preparations and growth regulators containing these compounds | �ݿ˹�����������ʵ��ֲ��ѧ�� | 2004-12-22 | — | — | CN | disclosed |
| EP-1475094-A1 | Pyrazolo[4,3-D]pyrimidines, process for their preparation and methods of use | Ustav Experimentalni Botaniky Akademie ved Ceské Republiky (CZ) | 2004-11-10 | — | — | EP | disclosed |
| WO-2004067518-A1 | SUBSTITUTED PYRIMIDINES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2004-08-12 | — | — | WO | disclosed |
| WO-2004058791-A2 | SUBSTITUTION DERIVATIVES OF N6-BENZYLADENOSINE, METHODS OF THEIR PREPARATION, THEIR USE FOR PREPARATION OF DRUGS, COSMETIC PREPARATIONS AND GROWTH REGULATORS, PHARMACEUTICAL PREPARATIONS, COSMETIC PREPARATIONS AND GROWTH REGULATORS CONTAINING THESE COMPOUNDS | USTAV EXPERIMENTALNI BOTANIKY AKADEMIE VED CESKE REPUBLIKY (CZ) | 2004-07-15 | — | — | WO | disclosed |
| EP-1348707-A1 | Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy | Ustav Experimentalni Botaniky AV CR (Institute of Experimental Botany Academy of Sciences of the Czech Republic) (CZ) | 2003-10-01 | — | — | EP | disclosed |
| US-4388250-A | FROM HYDROXYBENZALDEHYDE | RHONE POULENC INC. (US) | 1983-06-14 | — | — | US | disclosed |
| US-4196291-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRAENKTER HAFTUNG (DE) | 1980-04-01 | — | — | US | disclosed |
| US-4141978-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1979-02-27 | — | — | US | disclosed |
| US-4113867-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1978-09-12 | — | — | US | disclosed |
| US-4001411-A | ANTHELMINTICS | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1977-01-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240000726-A1 | COMPOUNDS AND METHODS FOR SCAVENGING DICARBONYL ELECTROPHILES | OGG1, LGMN, GLO1 | IDO1 1729/4885ALOX5 490/4885PTGS2 81/4885 |
| US-12383515-B2 | Compositions and methods of use of γ-ketoaldehyde scavengers for treating, preventing or improving nonalcoholic fatty liver disease (NAFLD), NASH, ALD or conditions related to the liver | AKR7A2, CPT1A, FABP1 | IDO1 840/4885ALOX5 177/4885PTGS2 589/4885 |
| US-20230364032-A1 | USE OF 2-HOBA TO TREAT ATHEROSCLEROSIS | HACL2, APOB, OAT | IDO1 4126/4885ALOX5 1258/4885PTGS2 1034/4885 |
| US-20230355549-A1 | METHOD OF PREVENTING KIDNEY INJURY DISRUPTION OF INTESTINAL LYMPHATICS | FABP2, SI, MLN | IDO1 608/4885ALOX5 429/4885PTGS2 98/4885 |
| US-20230330049-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDHEYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING FIBROSIS OF THE LIVER | GGT1, GGH, AKR7A2 | IDO1 785/4885ALOX5 351/4885PTGS2 305/4885 |
| US-20250360094-A1 | COMPOSITIONS AND METHODS OF USE OF GAMMA-KETOALDEHYDE SCAVENGERS FOR TREATING, PREVENTING OR IMPROVING NONALCOHOLIC FATTY LIVER DISEASE (NAFLD), NASH, ALD OR CONDITIONS RELATED TO THE LIVER | CPT1A, AKR7A2, FABP1 | IDO1 788/4885ALOX5 169/4885PTGS2 619/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.